Physicians Total Care, Inc.
Overview
Physicians Total Care, Inc. is a privately held pharmaceutical company focused on providing prescription medications to healthcare professionals. The company specializes in meeting the unique medication needs of physicians and clinics. It aims to enhance patient care by offering a broad range of therapeutic solutions.
Therapeutic areas
FDA compliance signals
23 FDA enforcement records linked to this company.
- recall — Class II2014-11-12
CGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not manufactured with good manufacturing practices.
- recall — Class III2014-11-12
Failed Tablet/Capsule Specifications: Affected lot numbers may contain chipped or broken tablets.
- recall — Class II2014-01-01
Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.
- recall — Class II2013-08-07
Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.
- recall — Class II2013-06-12
Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.
- recall — Class III2013-06-12
Labeling: Incorrect or Missing Lot and/or Expiration Date; This recall is being initiated because the lot number and expiration date on the tube may not be legible.
- recall — Class III2013-06-05
Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing
- recall — Class III2013-05-15
Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).
- recall — Class III2013-05-08
Presence of Foreign Tablets/Capsules: One bottle of Percocet 10/325 mg was found to contain a tablet of Endocet 10/25 mg, the generic form.
- recall — Class II2013-04-03
Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API.
- recall — Class II2013-04-03
Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API.
- recall — Class II2013-03-27
Subpotent; 15 month stability (by mfr)
- warning_letter2013-01-10
FDA Warning Letter (drug product)
- recall — Class II2012-12-26
Presence of Particulate Matter: glass delamination
- recall — Class III2012-12-19
Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.